Ligand Pharmaceuticals Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Rental Revenue	29.7	29.71	30.32	28.09	22.42	17.53	Upgrade
Tenant Reimbursements	5.68	5.56	5.74	4.36	3.34	2.18	Upgrade
Other Revenue	0.32	0.33	0.31	0.26	0.23	0.27	Upgrade
Total Revenue	35.7	35.6	36.37	32.7	25.99	19.98	Upgrade
Revenue Growth (YoY	-2.34%	-2.12%	11.22%	25.82%	30.07%	21.06%	Upgrade
Property Expenses	11.47	11.47	10.55	8.92	7.54	5.9	Upgrade
Other Operating Expenses	0.09	0.08	0.64	0.08	0.08	-0.2	Upgrade
Total Operating Expenses	12.41	12.37	11.81	9.54	7.98	6.88	Upgrade
Operating Income	23.29	23.23	24.56	23.17	18.01	13.1	Upgrade
Interest Expense	-5.89	-5.65	-4.11	-5.34	-2.61	-2.51	Upgrade
Interest & Investment Income	1.79	2.86	2.26	2.13	2.29	1.37	Upgrade
Other Non-Operating Income	0.07	0.07	-0.46	-0.27	0	0.09	Upgrade
EBT Excluding Unusual Items	19.26	20.51	22.24	19.68	17.69	12.04	Upgrade
Gain (Loss) on Sale of Investments	1.58	0.07	-1.37	-2.07	-0.39	4.01	Upgrade
Gain (Loss) on Sale of Assets	-0.17	1.09	0.65	1.4	0.47	0.03	Upgrade
Asset Writedown	14.22	7.53	-7.76	-5.08	-0.35	-13.53	Upgrade
Other Unusual Items	-	-	-0.03	-0.24	-	-	Upgrade
Pretax Income	34.89	29.2	13.73	13.7	17.41	2.55	Upgrade
Income Tax Expense	0.91	0.6	0.53	0.29	0.35	0.03	Upgrade
Net Income	33.98	28.6	13.2	13.41	17.06	2.52	Upgrade
Net Income to Common	33.98	28.6	13.2	13.41	17.06	2.52	Upgrade
Net Income Growth	58.80%	116.72%	-1.58%	-21.42%	576.53%	-71.26%	Upgrade
Basic Shares Outstanding	-	4	4	4	4	4	Upgrade
Diluted Shares Outstanding	-	4	4	4	4	4	Upgrade
Shares Change (YoY)	-	-0.11%	-0.03%	0.05%	-0.01%	136.96%	Upgrade
EPS (Basic)	-	6.87	3.17	3.22	4.09	0.61	Upgrade
EPS (Diluted)	-	6.87	3.17	3.22	4.09	0.60	Upgrade
EPS Growth	-	116.96%	-1.55%	-21.39%	581.67%	-87.36%	Upgrade
Dividend Per Share	-	4.100	4.000	3.800	3.600	3.250	Upgrade
Dividend Growth	-	2.50%	5.26%	5.56%	10.77%	-7.14%	Upgrade
Operating Margin	65.25%	65.24%	67.53%	70.84%	69.31%	65.55%	Upgrade
Profit Margin	95.17%	80.33%	36.28%	41.00%	65.65%	12.62%	Upgrade
EBITDA	-	-	24.66	23.27	23.96	19.05	Upgrade
EBITDA Margin	-	-	67.80%	71.15%	92.20%	95.33%	Upgrade
D&A For Ebitda	-	-	0.1	0.1	5.95	5.95	Upgrade
EBIT	23.29	23.23	24.56	23.17	18.01	13.1	Upgrade
EBIT Margin	65.25%	65.24%	67.53%	70.84%	69.31%	65.55%	Upgrade
Effective Tax Rate	2.62%	2.04%	3.88%	2.11%	2.02%	1.14%	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.